Circulating tumor cells (CTCs) are tumor-derived cells that enter the bloodstream after detaching from the primary tumor or metastatic sites during cancer invasion and metastasis. Their formation depends primarily on the ability of tumor cells to migrate and breach tissue structural barriers. Once formed, CTCs exist either as single cells or as multicellular clusters in the blood, representing a prerequisite and necessary condition for distant dissemination of solid tumors.

• 

  Rare Cell Capture Platform

  Rare Cell Capture Platform

  Modular chip design, high efficiency, high throughput, multiple body fluid types, enabling precise capture of various viable rare cells, including CTCs and stem cells.

• 

  CTC 3D Culture Technology Platform

  CTC 3D Culture Technology Platform

  CTC 3D Culture Technology Platform

• 

  High-Sensitivity CTC Drug Susceptibility Testing Platform

  High-Sensitivity CTC Drug Susceptibility Testing Platform

  "Drug testing in vitro" for precision medicine — transitioning from "experience-based medication" to "data-driven decision-making"